Hospital
Warsaw Health System LLC
Warsaw Health System LLC was paid $9.95M by Medicaid between Jan 2018 and Nov 2024, across 100 billing codes. Its largest line is 99284, emergency room visit (serious) — 24% of everything it billed.
33Billing provider infoWARSAW HEALTH SYSTEM LLC
WARSAW, IN 46580
WARSAW, IN 46580
33aNPI1164475711assigned 05/17/2006
33bProvider typeGeneral Acute Care Hospital
28Total paid$9.95M
24GClaims228,889
24DCodes billed100
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers
Next to other General Acute Care Hospital providers in Indiana
Rank by total paid#34 of 69
Median peer was paid$9.76M
This provider vs. median1.0×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official LALOR, PAULA controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 21,672 | $312K | |
| 2019 | 20,509 | $641K | |
| 2020 | 19,949 | $838K | |
| 2021 | 34,615 | $1.65M | |
| 2022 | 50,076 | $2.43M | |
| 2023 | 48,963 | $2.36M | |
| 2024incomplete | 33,105 | $1.73M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 24% | 16,389 | 12,336 | $2.42M |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 22% | 14,624 | 11,924 | $2.19M |
| 71045 | Radiologic examination, chest; single view | 8.9% | 7,078 | 5,231 | $889K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 7.4% | 5,780 | 4,234 | $735K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 7.3% | 1,863 | 1,311 | $722K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 4.7% | 9,245 | 5,986 | $470K |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 3.3% | 5,677 | 4,443 | $331K |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 2.6% | 3,483 | 2,552 | $258K |
| 70450 | Computed tomography, head or brain; without contrast material | 2.3% | 2,476 | 1,797 | $232K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 1.8% | 7,362 | 5,806 | $182K |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | 1.4% | 152 | 110 | $143K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 1.2% | 763 | 542 | $117K |
88 more codes
| 80053 | Comprehensive metabolic panel | 1.2% | 20,248 | $115K |
| 96361 | Intravenous infusion, hydration; each additional hour | 1.1% | 4,207 | $108K |
| 80050 | General health panel | 1.0% | 968 | $104K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 1.0% | 1,027 | $100K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 8,066 | $97K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 24,116 | $94K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 820 | $74K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 5,260 | $63K |
| 84484 | <1% | 7,605 | $43K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 21,774 | $39K |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 221 | $33K |
| 29581 | <1% | 739 | $33K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 951 | $30K |
| 71275 | Computed tomographic angiography, chest, with contrast material | <1% | 76 | $26K |
| 29580 | <1% | 661 | $23K | |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 2,497 | $23K |
| 87430 | <1% | 1,545 | $18K | |
| 83690 | <1% | 5,622 | $17K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 858 | $16K |
| 81001 | <1% | 7,612 | $13K | |
| 80061 | Lipid panel | <1% | 1,619 | $12K |
| 83605 | <1% | 1,995 | $12K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 3,451 | $11K |
| 99221 | <1% | 38 | $10K | |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 254 | $10K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 923 | $9K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 257 | $8K |
| 87040 | <1% | 1,720 | $8K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 1,409 | $7K |
| 72131 | <1% | 35 | $6K | |
| 87081 | <1% | 1,130 | $6K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 406 | $6K |
| 83880 | <1% | 300 | $5K | |
| 99238 | Hospital discharge day management, 30 minutes or less | <1% | 21 | $5K |
| 81003 | <1% | 4,083 | $5K | |
| 82607 | <1% | 432 | $4K | |
| 95816 | <1% | 13 | $4K | |
| 85379 | <1% | 677 | $4K | |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | <1% | 138 | $4K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 140 | $4K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 140 | $4K |
| 74018 | <1% | 31 | $4K | |
| 85730 | <1% | 1,367 | $4K | |
| 99218 | <1% | 19 | $4K | |
| 85610 | <1% | 1,675 | $3K | |
| 84703 | <1% | 635 | $3K | |
| 73630 | <1% | 120 | $3K | |
| 82077 | <1% | 221 | $3K | |
| 87807 | <1% | 246 | $3K | |
| 83735 | <1% | 880 | $3K | |
| 99214 | Doctor's office visit, returning patient (more involved) | <1% | 18 | $2K |
| 80076 | <1% | 1,207 | $2K | |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | <1% | 27 | $2K |
| 84145 | <1% | 88 | $2K | |
| 84450 | <1% | 488 | $2K | |
| 87400 | <1% | 118 | $2K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 86 | $1K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 228 | $879.51 |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 17 | $847.63 |
| 81025 | <1% | 160 | $811.72 | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 175 | $801.68 |
| 86803 | <1% | 63 | $682.55 | |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 14 | $500.78 |
| 99213 | Doctor's office visit, returning patient (routine) | <1% | 19 | $446.59 |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | <1% | 48 | $444.82 |
| 85027 | <1% | 82 | $362.62 | |
| 84439 | <1% | 91 | $362.02 | |
| 82378 | <1% | 14 | $151.68 | |
| 83615 | <1% | 49 | $147.07 | |
| 82746 | <1% | 17 | $145.54 | |
| 80069 | <1% | 36 | $104.16 | |
| 86850 | <1% | 28 | $102.25 | |
| 87077 | <1% | 14 | $88.88 | |
| 83550 | <1% | 13 | $78.66 | |
| 84550 | <1% | 31 | $78.42 | |
| 83540 | <1% | 13 | $58.23 | |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 5,173 | $53.67 |
| 86900 | <1% | 28 | $50.83 | |
| 86901 | <1% | 28 | $50.83 | |
| 82043 | <1% | 17 | $18.69 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 3,946 | $0.50 |
| J2270 | Injection, morphine sulfate, up to 10 mg | 0% | 63 | $0.00 |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | 0% | 17 | $0.00 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 0% | 1,061 | $0.00 |
| J2704 | Injection, propofol, 10 mg | 0% | 708 | $0.00 |
| J1170 | Injection, hydromorphone, up to 4 mg | 0% | 181 | $0.00 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 0% | 369 | $0.00 |
| J0690 | Injection, cefazolin sodium, 500 mg | 0% | 14 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialLALOR, PAULA (DIRECTOR/DELEGATED OFFICIAL)
| Provider | Location | Paid |
|---|---|---|
| Northwest Hospital LLC | Tucson, AZ | $47.81M |
| Roswell Hospital Corporation | Roswell, NM | $41.27M |
| Wesley Health System LLC | Hattiesburg, MS | $37.82M |
| Metro Knoxville Hma LLC | Powell, TN | $28.70M |
| Bullhead City Hospital Corporation | Bullhead City, AZ | $28.54M |
| Iom Health System LP | Fort Wayne, IN | $27.50M |
| ST. Joseph Health System, LLC | Fort Wayne, IN | $25.43M |
| Laredo Texas Hospital Company LP | Laredo, TX | $19.46M |
| Oak Hill Hospital Corporation | Oak Hill, WV | $18.77M |
| Cocke County Hma, LLC | Newport, TN | $18.34M |
| Cleveland Tennessee Hospital Company LLC | Cleveland, TN | $16.31M |
| Jefferson County Hma LLC | Jefferson City, TN | $14.31M |
| Northwest Arkansas Hospitals, LLC | Springdale, AR | $11.46M |
| Petersburg Hospital Company LLC | Petersburg, VA | $11.20M |
| Campbell County Hma, LLC | Lafollette, TN | $10.07M |
| Longview Medical Center LP | Longview, TX | $9.29M |
| Moberly Hospital Company LLC | Moberly, MO | $8.61M |
| Crestview Hospital Company, LLC | Crestview, FL | $8.15M |
| Kirksville Missouri Hospital Company, LLC | Kirksville, MO | $7.98M |
| Victoria of Texas LP | Victoria, TX | $7.74M |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.